ConductScience.org, home

Paper26855152

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas.

Heinzelmann F and 19 others. Bone Marrow Transplant, 2016. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas. Papers, record 26855152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26855152

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas.
PubMed
Journal
Bone Marrow Transplant
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.29
iCite
Revised in PubMed
2026-01-27
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heinzelmann FF
2Bethge WW
3Beelen DWD W
4Engelhard MM
5Kröger NN
6Dreger PP
7Niederwieser DD
8Finke JJ
9Bunjes DD
10Tischer JJ
11Kobbe GG
12Holler EE
13Bornhäuser MM
14Stelljes MM
15Baurmann HH
16Müller AA
17Haubitz II
18Schrezenmeier HH
19Müller CC
20Ottinger HH

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hematopoietic Stem Cell TransplantationMajor topic
Lymphoma, FollicularMajor topic
Adolescent
Adult
Age Factors
Aged
Female
Germany
Graft vs Host Disease
Humans
Male
Middle Aged
Prognosis
Registries
Salvage Therapy
Survival Rate
Tissue Donors
Transplantation Conditioning
Treatment Outcome
Whole-Body Irradiation
Young Adult

Source PubMed

Download CSV of topics

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110717153Radiobiological and Clinical Bases for Total Body Irradiation in the Leukemias and Lymphomas.Semin Radiat Oncol1995https://conductscience.org/library/papers/10717153PubMed
215937505Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: a retrospective survey of 112 adult patients in Japan.Bone Marrow Transplant2005https://conductscience.org/library/papers/15937505PubMed
319793383Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.Br J Haematol2009https://conductscience.org/library/papers/19793383PubMed
425193988
The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party.
Ann Oncol2014https://conductscience.org/library/papers/25193988PubMed
523843495Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000).Blood2013https://conductscience.org/library/papers/23843495PubMed
626332003CAR-T Cell Therapy for Lymphoma.Annu Rev Med2016https://conductscience.org/library/papers/26332003PubMed
717488686
Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).
Haematologica2007https://conductscience.org/library/papers/17488686PubMed
823777769Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience.Blood2013https://conductscience.org/library/papers/23777769PubMed
918311781
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
Cancer2008https://conductscience.org/library/papers/18311781PubMed
1017242396Revised response criteria for malignant lymphoma.J Clin Oncol2007https://conductscience.org/library/papers/17242396PubMed
1124450858PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.N Engl J Med2014https://conductscience.org/library/papers/24450858PubMed
126996481Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.Am J Med1980https://conductscience.org/library/papers/6996481PubMed
1321810687Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: the phase II VERTICAL study.J Clin Oncol2011https://conductscience.org/library/papers/21810687PubMed
1423233613Changing role of stem cell transplantation in follicular lymphoma.Hematology Am Soc Hematol Educ Program2012https://conductscience.org/library/papers/23233613PubMed
1516455952Age and acute myeloid leukemia.Blood2006https://conductscience.org/library/papers/16455952PubMed
1611739162Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.Blood2001https://conductscience.org/library/papers/11739162PubMed
1715304395Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma.Blood2004https://conductscience.org/library/papers/15304395PubMed
1818559872Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.J Clin Oncol2008https://conductscience.org/library/papers/18559872PubMed
1924043582Clinical outcomes of allogeneic stem cell transplantation for relapsed or refractory follicular lymphoma: a retrospective analysis by the Fukuoka Blood and Marrow Transplantation Group.Int J Hematol2013https://conductscience.org/library/papers/24043582PubMed
2023708704
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation.
Bone Marrow Transplant2013https://conductscience.org/library/papers/23708704PubMed

See all 61 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
36428762Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups.Cancers (Basel)2022https://conductscience.org/library/papers/36428762PubMed
33311593Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors.Bone Marrow Transplant2021https://conductscience.org/library/papers/33311593PubMed
32670277The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction.Front Immunol2020https://conductscience.org/library/papers/32670277PubMed
30112190Systematic review of therapy used in relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma.Future Sci OA2018https://conductscience.org/library/papers/30112190PubMed
29623467Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma.J Cancer Res Clin Oncol2018https://conductscience.org/library/papers/29623467PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26855152

GET https://conductscience.org/api/papers/v1/26855152/references?page=2